Medtronic Submits 510(k) Applications for Interoperable Diabetes Management System
US-Irish firm Medtronic plc (NYSE: MDT) has submitted twin 510(k) applications to the U.S. Food...
Thermo Fisher Announces $2 Billion US Investment to Strengthen Life Sciences Infrastructure
US-based life sciences giant Thermo Fisher Scientific Inc. (NYSE: TMO) has announced a USD 2...
Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics
German pharmaceutical major Merck KGaA (ETR: MRK) is reportedly nearing the completion of its acquisition of...
CN Bio and Pharmaron Partner to Validate and Expand OOC Technology Applications
CN Bio, a UK-based provider of Organ-on-a-chip (OOC) systems and solutions, has entered into a...
Gan & Lee Pharmaceuticals Reports 417 Million USD Revenue and 80.75% Profit Surge in 2024
Gan & Lee Pharmaceuticals (SHA: 603087) reported revenues of RMB 3.045 billion (USD 417 million)...
Hepalink Secures SAHPRA Approval for Ivenoxin in South Africa
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE: 002399, HKG: 9989) has announced that it has...
Akeso’s Penpulimab Gains FDA Approval for Nasopharyngeal Carcinoma Treatment
China-based Akeso, Inc. (HKG: 9926) announced that it has received marketing approval from the US...
Sanofi Reports Q1 Sales Growth Driven by Dupixent and New Product Launches
French pharmaceutical giant Sanofi (NASDAQ: SNY) released its Q1 2025 financial results, reporting global net...
Shineco Inc. Announces Acquisition of InfiniClone for Regenerative Medicine Expansion
US-based Shineco Inc. (NASDAQ: SISI) announced that its subsidiary Shineco Life Sciences Group Hong Kong...
Shenzhen Core Medical Closes Series D Round to Advance Miniaturized Artificial Hearts
Shenzhen Core Medical Technology Co., Ltd, a developer of mechanical circulation assist systems, has reportedly...
Doer Biologics Begins Phase II Study of DR10624 for Steatotic Liver Disease
China-based Zhejiang Doer Biologics Co., Ltd has announced the first patient dosing in a Phase...
Boehringer Ingelheim Partners with Tessellate Bio on ALT Cancer Therapies
Boehringer Ingelheim (BI), a German pharmaceutical leader, has entered into a strategic collaboration and global...
Genentech Collaborates with Repertoire Immune Medicines on Autoimmune Disease Therapies
Genentech, a subsidiary of Swiss pharmaceutical leader Roche (SWX: ROG, OTCMKTS: RHHBY) , announced a collaboration...
AstraZeneca Expands AI Partnership with Tempus AI and Pathos AI for Oncology Research
UK pharmaceutical leader AstraZeneca (AZ, NASDAQ: AZN) has expanded its collaboration with US-based Tempus AI,...
Boston Scientific Reports 20.9% Revenue Growth in Q1 2025 Financial Results
US medical technology giant Boston Scientific Corporation (NYSE: BSX) released its Q1 2025 financial report,...
Roche Launches Navify Chest Pain Triage Algorithm With CE Mark
Swiss healthcare giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced today that it has received CE...
Trump Administration Considers Tying US Drug Prices to International Benchmarks
Reuters reported that the Trump administration is exploring a policy to tie domestic drug prices...
Baheal Partners with Jiluntai for Commercialization of Technetium-99m-labeled Imaging Agent
China-based health services and distribution giant Baheal Pharmaceutical Group (SHE: 301015) has entered into a...
PingAn Good Doctor Reports Q1 2025 Revenue Growth and Net Profit Turnaround
China-based Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good...
MicroPort MedBot Gains NMPA Clearance for Toumai’s Remote Surgery Across Departments
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced receiving clearance from China’s National...